← Back to Search

Clot Foam for Bleeding

Phase 1
Waitlist Available
Led By Grant Bochicchio, MD, MPH FACS
Research Sponsored by Biomedica Management Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is expected to survive 6 months from the date of screening, If female and of child-bearing potential, subject has a negative serum pregnancy test prior to surgery and agrees to not breast feed her child (if applicable) for duration of study treatment and completion of study follow-up visits, If subject is a sexually active male or a sexually active female of child-bearing potential, subject agrees to use a medically accepted form of contraception from the time of consent to completion of all follow-up study visits
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

Phase 1 Single-Arm Study Evaluating ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery in Which Liver Bleeding is Encountered.

Eligible Conditions
  • Bleeding

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
control mild-to-moderate bleeding during surgery in which liver bleeding in encountered
Secondary outcome measures
Hemostatic Success

Trial Design

1Treatment groups
Experimental Treatment
Group I: Clot FoamExperimental Treatment1 Intervention
Application of Clotfoam

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Biomedica Management CorporationLead Sponsor
Washington University School of MedicineOTHER
1,933 Previous Clinical Trials
2,299,705 Total Patients Enrolled
2 Trials studying Bleeding
194 Patients Enrolled for Bleeding
Grant Bochicchio, MD, MPH FACSPrincipal InvestigatorWashington University School of Medicine Barnes Jewish Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery - Liver Bleeding is Encountered
George Falus 2014. "ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery - Liver Bleeding is Encountered". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02264730.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top